ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Kennedy Attempts To Establish Unit For All Biomedical Research Similar To Successful Cancer Panel; Administration Threatens Veto

March 15, 1974

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

January 14, 1977

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

NCAB Gives Final Approval to New Guidelines for P01s

May 29, 1987

Also Weber returns to M.D. Anderson.

August 8, 2003